Role of elastin in pathologic calcification of xenograft heart valves

Journal of Biomedical Materials Research - Part A

Volumn 66, Issue 1, 2003, Pages 93-102

  Bailey, Michael T ^a   Pillarisetti, Swadeep ^a   Xiao, Hui ^a   Vyavahare, Naren R ^a  

^a AMRL   (United States)

Author keywords

Aorta; Bioprosthetic heart valves; Calcification; Cellular xenograft tissue engineering scaffolds; Elastin

Indexed keywords

AMINO ACIDS; CALCIFICATION (BIOCHEMISTRY); CELLS; DNA; GRAFTS; HEART VALVE PROSTHESES; PATHOLOGY; PHOSPHOLIPIDS; PROTEINS;

ELASTIN-RICH AORTIC MATRICES;

BIOMIMETIC MATERIALS;

AMINO ACID; COLLAGEN; CYANOGEN BROMIDE; DEOXYRIBONUCLEASE; DNA; DYE; ELASTIN; PHOSPHOLIPID; RIBONUCLEASE; SCLEROPROTEIN; SODIUM HYDROXIDE; TRYPSIN INHIBITOR; CROSS LINKING REAGENT; GLUTARALDEHYDE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA WALL; ARTICLE; CALCIFICATION; CONTROLLED STUDY; EXPLANT; EXTRACTION; HEART VALVE BIOPROSTHESIS; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; STAINING; SWINE; TISSUE ENGINEERING; TRICHROME STAIN; XENOGRAFT; ANIMAL; AORTA DISEASE; BIOPROSTHESIS; CALCINOSIS; CHEMISTRY; CYTOLOGY; DERMIS; DRUG EFFECT; ELASTIC TISSUE; EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS; HETEROTOPIC TRANSPLANTATION; METABOLISM; POSTOPERATIVE COMPLICATION; TRANSPLANTATION;

AMINO ACIDS; ANIMALS; AORTA; AORTIC DISEASES; BIOPROSTHESIS; CALCINOSIS; CROSS-LINKING REAGENTS; CYANOGEN BROMIDE; DERMIS; DNA; ELASTIC TISSUE; ELASTIN; EXTRACELLULAR MATRIX; GLUTARAL; HEART VALVE PROSTHESIS; MALE; PHOSPHOLIPIDS; POSTOPERATIVE COMPLICATIONS; RATS; SODIUM HYDROXIDE; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HETEROTOPIC; TRYPSIN;

EID: 0344306398     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10543     Document Type: Article

References (38)

1. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21.
2. Levy RJ. Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves. J Heart Valve Dis. 1994;3:101-104.
3. Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep. J Thorac Cardiovasc Surg. 1994;108:880-887.
4. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439-465.
5. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439-465.
6. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-488.
7. Moore MA, Phillips RE Jr., McIlroy BK, Walley VM, Hendry PJ. Evaluation of porcine valves prepared by dye-mediated photooxidation. Ann Thorac Surg. 1998;66:S245-S248.
8. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation. 1994;90:323-329.
9. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res. 1993;27:1477-1484.
10. David TE. Aortic valve replacement with stentless porcine bioprostheses. J Cardiovasc Surg. 1998;13:344-351.
11. Biedrzycki LM, Lerner E, Levy RJ, Schoen FJ. Differential calcification of cusps and aortic wall of failed stented porcine bioprosthetic valves. J Biomed Mater Res. 1997;34:411-415.
12. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998;42:30-37.
13. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000;102:11150-11155.
14. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: a biomaterials approach for coronary artery by-pass and heart valve replacement. Ann Thorac Surg. 1995;60: S353-S358.
15. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg. 2000;70:1962-1969.
16. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000;19:381-386.
17. Rasmussen BL, Bruenger E, Sandberg LB. A new method for purification of mature elastin. Anal Biochem 1975;64:255-259.
18. Lansing AI, Alex M, Rosenthal TB. The structure and chemical characterization of elastic fibers as revealed by elastase and by electron microscopy. Anat Record 1952;114:555.
19. Chen P, Toribara T, Warner H. Microdetermination of phosphorus. Anal Chem 1956;28:1756.
20. Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol 1999;155:973-982.
21. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-532.
22. Meuris B, Ozaki S, Herijgers P, Verbeken E, Flameng W. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue. Semin Thorac Cardiovasc Surg 2001;13:99-105.
23. Malanik V, Ledvina M. A comparative study of two isolation procedures for elastin and contaminating substances in fetal and adult rabbit aortas. Connect Tissue Res. 1978;6:139-143.
24. Soskel NT, Sandburg LB. A comparison of six methods of extracting elastin residue from hamster lungs. Exp Lung Res 1983;4:109-119.
25. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.
26. Girardot MN, Torrianni M, Girardot JM. Effect of AOA on glutaraldehyde-fixed bioprosthetic heart valve cusps and walls: binding and calcification studies. Int J Artif Organs. 1994;17:76-82.
27. Cleveland DC, Williams WG, Razzouk AJ, Trusler GA, Rebeyka IM, Duffy L, Kan Z, Coles JG, Freedom RM. Failure of cryopreserved homograft valved conduits in the pulmonary circulation. Circulation 1992;86:11150-11153.
28. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998;115:118-127.
29. Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations. Am J Pathol 1992;141:487-496.
30. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983;113:143-155.
31. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, Lund SA. Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol 1986;122:71-82.
32. Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol 1983;52:629-631.
33. Vyavahare N, Jones PL, Tallapragada S, Levy RJ. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol 2000;157:885-893.
34. Bestetti-Bosisio M, Cotelli F, Schiaffino E, Sorgato G, Schmid C. Lung calcification in long-term dialysed patients: a light and electronmicroscopic study. Histopathology 1984;8:69-79.
35. Robert L, Bizbiz L, Alperovitch A, Bonithon-Kopp C. Elastolysis, aging and atherogenesis. C R Seances Soc Biol Fil 1995;189:853-859.
36. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA Jr., Willerson JT, Ferrans VJ. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 1998;98:11331-11337.
37. Saulnier JM, Hauck M, Fulop T Jr., Wallach JM. Human aortic elastin from normal individuals and atherosclerotic patients: lipid and cation contents; susceptibility to elastolysis. Clin Chim Acta 1991;200:129-136.
38. Spina M, Garbin G. Age-related chemical changes in human elastins from non-atherosclerotic areas of thoracic aorta. Atherosclerosis 1976;24:267-79.